Clinical Trial Results:
Omission of surgery and sentinel lymph node dissection in clinically low-risk HER2positive breast cancer with high HER2 addiction and a complete response following standard anti- HER2-based neoadjuvant therapy (ELPIS trial)
|
Summary
|
|
EudraCT number |
2019-005019-18 |
Trial protocol |
ES |
Global completion date |
|
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
01 Feb 2026
|
First version publication date |
01 Feb 2026
|
Other versions |
|
Summary report(s) |
ELPIS_Submission_note ELPIS_Statistical Analysis Report (SAR) |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.